Calithera Biosciences
Calithera Biosciences is a clinical-stage biopharmaceutical company focused on developing targeted therapies for patients with cancer and other life-threatening diseases. Leveraging expertise in tumor biology and immunology, Calithera Biosciences advances innovative small molecule therapeutics designed to address unmet medical needs. The company’s research pipeline includes novel agents that modulate key metabolic and immuno-oncology pathways, aiming to improve patient outcomes through precision medicine. By collaborating with industry partners and utilizing cutting-edge scientific approaches, Calithera Biosciences is committed to delivering impactful solutions in oncology and beyond. The company’s dedication to rigorous clinical development underscores its mission to transform the treatment landscape for patients worldwide.
